Contract SPE2D217D0059
Anip Acquisition Co · Department Of Defense · September 11, 2017
Anip Acquisition Co was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on September 11, 2017 for an undisclosed amount of work in medicinal and botanical manufacturing. It was awarded under full and open competition. The contract has been modified 8 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 8, 2021. If all options are exercised, the contract could reach $9.06 million.
Contract details
- PIID
- SPE2D217D0059
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325411 · Medicinal And Botanical Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 11, 2017
- Latest action
- September 8, 2021
Description
4610036344!MANUFACTURE/DISTRIBUTOR BR-PH
Modification timeline
-
September 8, 2021Mod P00008$0
-
September 9, 2020Mod P00007$0
-
September 8, 2020Mod P00006$0
-
August 10, 2020Mod P00005$0
-
August 26, 2019Mod P00004$0
-
September 6, 2018Mod P00003$0
-
July 26, 2018Mod P00002$0
-
May 8, 2018Mod P00001$0
-
September 11, 2017Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $232 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $13.1K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $1.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $220.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $135 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $39.8K |
Top contractors in NAICS 325411
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 372,977 | $24.02B |
| 2 | Amerisourcebergen Drug Corp | 1,414,856 | $18.32B |
| 3 | Glaxosmithkline, Llc | 44 | $5.42B |
| 4 | Merck Sharp & Dohme Llc | 3 | $1.50B |
| 5 | Novartis Vaccines And Diagnostics, Inc. | 132 | $1.07B |
| 6 | Sanofi Vaccines Us Inc. | 57 | $650.53M |
| 7 | Cardinal Health, Inc. | 42,916 | $603.29M |
| 8 | Dms Pharmaceutical Group Inc | 113,930 | $547.06M |
| 9 | Cardinal Health 100, Inc | 7,655 | $486.24M |
| 10 | Glaxosmithkline Holdings (Americas) Inc. | 72 | $280.01M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract SPE2D217D0059?
Contract SPE2D217D0059 is a federal contract awarded to Anip Acquisition Co by Department Of Defense on September 11, 2017 for an undisclosed amount of work classified under MEDICINAL AND BOTANICAL MANUFACTURING. It has been modified 8 times since the base award.
Who won contract SPE2D217D0059?
Anip Acquisition Co won contract SPE2D217D0059 from Department Of Defense.
How much is contract SPE2D217D0059 worth?
Contract SPE2D217D0059 has obligated $0 to date but carries a potential ceiling of $9.06 million if fully funded and all options are exercised.